Show
Sort by
-
Lessons learned about appendiceal neuroendocrine neoplasms from data analysis of the Belgian Cancer Registry 2010-2015
-
Current practice in approaching controversial diagnostic and therapeutic topics in gastroenteropancreatic neuroendocrine neoplasm management : Belgian multidisciplinary expert discussion based on a modified Delphi method
-
A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer
-
Feasibility of radiotherapy with concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma: a prospective dose finding phase I-II study
-
Diagnostic pitfalls in digestive neuroendocrine tumours
-
Role of chemotherapy in gastro-entero-pancreatic neuroendocrine tumors: the end of a story?
-
The antiproliferative effect of somatostatin analogs: clinical relevance in patients with neuroendocrine gastro-entero-pancreatic tumours.
-
The potential role of targeted therapies in the management of neuroendocrine tumours
-
Locoregional and radioisotopic targeted treatment of neuroendocrine tumours
-
Carcinoid heart disease: a hidden complication of neuroendocrine tumours